Antipicornaviral compounds and compositions, their pharmaceutical uses, and materials for their synthesis

Compounds of formula I (see below) are disclosed, where the formula variables are as defined in the disclosure. Compounds of formula I advantageously inhibit or block the biological activity of the picornaviral 3C protease. These compounds, as well as pharmaceutical compositions containing these com...

Full description

Saved in:
Bibliographic Details
Main Authors HUA, YE, HENDRICKSON, THOMAS F, JOHNSON, THEODORE O, CHAN, FORA P, CHU, SHAO SONG, SKALITZKY, DONALD JAMES, REICH, SIEGFRIED HEINZ, EASTMAN, BRIAN WALTER, YANG, YI, LUU, HIEP T
Format Patent
LanguageEnglish
Published 27.08.2004
Edition7
Subjects
ACYCLIC OR CARBOCYCLIC COMPOUNDS
CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online AccessGet full text

Cover

More Information
Summary:Compounds of formula I (see below) are disclosed, where the formula variables are as defined in the disclosure. Compounds of formula I advantageously inhibit or block the biological activity of the picornaviral 3C protease. These compounds, as well as pharmaceutical compositions containing these compounds, are useful for treating patients or hosts infected with one or more picornaviruses, such as RVP. Intermediates and synthetic methods for preparing such compounds are also described.
Bibliography:Application Number: NZ20010523134